EMA Reflection paper on IVR/IWR systems
Over the last 15 years there has been an increasing utilisation of interactive voice response systems (IVRS) utilising telephones. Such systems have been developed further into interactive web based systems (IWRS) utilising the internet. These systems were developed initially to optimise drug availability at sites. However, this has expanded into other areas such as dose titration, unblinding and expiry date updating. This of course may, if not handled appropriately, pose an increased risk to the patient and so IVRS/IWRS is of increasing interest to National Competent Authorities (NCAs).
This draft paper seeks to provide guidance to Member States on what the expectations are of these systems and in particular their use in expiry updating.
The end of consultation (deadline for comments) is 15 February 2012. Comments should be provided using this template. The completed comments form should be sent to gcp@ema.europa.eu.
Related GMP News
17.10.2024FDA's final Q&A Document on Electronic Systems & Data in Clinical Trials
17.10.2024EMA Guideline on Quality and Equivalence of Topical Products
05.09.2024Clinical Trials Regulation - Version 6.9 of the Q&As
23.07.2024Pilot Results on Regulatory-Led RWE Generation
23.07.2024ICH M12 Guideline on Drug Interaction Studies
20.06.2024Draft ICH M14 Guideline on Real-World Data for Safety Assessment